Beam Therapeutics's total assets for Q4 2025 were $1.48B, an increase of 12.97% from the previous quarter. BEAM total liabilities were $242.82M for the fiscal quarter, a -29.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.